Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBPET.L Regulatory News (BPET)

  • There is currently no data for BPET

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Update

2 Jun 2006 12:12

F&C Private Equity Trust PLC02 June 2006 To: RNS Date: 2 June 2006 F&C Private Equity Trust plcReport at 30 April 2006 • NAV increases of 11.8%, 3.9% and 9.9% for A, B and C shares • Strong uplifts and realisations • Several new commitments • Change of Year End to December The NAV per A (realisation) share at 30 April was 36.56p. Taking into accountthe special dividend of 7.5p paid on 14 April, this is an increase of 11.8% overthe quarter. The Net Assets of the A pool were £24.5m. The NAV per B(continuation) share at 30 April was 159.77p, an increase over the quarter of3.9%. The Net Assets of the B pool were £93.8m. The NAV per C (conversion)share at 30 April was 109.2p, an increase over the quarter of 9.85%. The NetAssets of the C pool were £23.0m. The A pool has shown a substantial increase reflecting continuing realisationsand some uplifts in value in its increasingly mature and concentrated portfolio.At 30 April the A pool had net cash of £3.8m. It is anticipated that thiswill be distributed once the company's distributable reserves have beenincreased through reduction of the share premium account. Principalcontributors to the uplift have included the Candover 1997 Fund (+£1.2m),International Mezzanine Investment (+£0.4m) and Hicks, Muse, Tate & Furst FundIV (+£0.3m). These funds have had or will imminently have realisations.Additionally we have re-valued our direct holding in Dakota Minnesota andEastern Railroad by £1.3m, reflecting this company's strong trading. In the B pool, there has also been a good flow of realisations with £3.5mreturned by funds during the quarter. Drawdowns from funds totalled £3.6m. Inaddition F&C Private Equity Trust invested £2m in LMS, a legal outsourcingcompany. This deal was a co-investment led by RJD Partners. Several newcommitments to private equity funds were made during the quarter or shortlyafterwards. These included €7.5m to Chequers Capital XV (France), $10m to BluePoint Capital Partners II (USA); €5m to Ibersuizas II (Spain); £4m to PiperPrivate Equity Fund IV; €5m to Life Sciences Partners III (European LifeSciences) and £10m to Inflexion 2006 Buyout Fund. Additionally we have invested£2m and committed £1m in HPF, a fund established to hold various Inflexion ledinvestments. The total un-drawn commitments of the B-pool amount to £124m.These may be drawn down over periods of up to 5 years. The C pool, which contains the former Discovery Trust Assets, is being steadilysold down to provide funds for investment in private equity. During thisquarter a further £14m of cash has been raised and this will transfer to the Bpool through the conversion process. 83% of the original C pool has so far beenrealised and the final conversion will take place in September 2006, based uponthe respective B and C share NAVs at 31 July. In order to more closely match the reporting periods of our underlying fundinvestments and to make performance comparisons easier your board has decided tochange the company's year end to 31 December, from 31 July. This will leadinitially to a 17 month accounting period for the current financial year, withthe move to a calendar year accounting commencing in 2007. For more information please contact: Hamish Mair 0131 465 1184 Hamish.mair@fandc.com Martin Cassels 0131 465 1095 Martin.cassels@fandc.com Alastair Moreton, Arbuthnot Securities Ltd 020 7012 2000 alastairmoreton@arbuthnot.co.uk Gordon Neilly / Sue Ingles, Intelli Corporate Finance 020 7 653 6300 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
30th Jun 20223:22 pmRNSChange of Name
17th Jun 20224:07 pmRNSTransaction in Own Shares
15th Jun 20225:01 pmRNSTransaction in Own Shares
27th May 20229:08 amRNSResult of Annual Gen Meeting & Directorate Change
26th May 202212:02 pmRNS1st Quarter Results
27th Apr 202210:07 amRNSDirector/PDMR Shareholding
27th Apr 202210:06 amRNSDirector/PDMR Shareholding
27th Apr 202210:04 amRNSDirector/PDMR Shareholding
26th Apr 20223:24 pmRNSDirector/PDMR Shareholding
26th Apr 20223:23 pmRNSDirector/PDMR Shareholding
25th Apr 20229:24 amRNSDirector/PDMR Shareholding
8th Apr 20227:00 amRNSAnnual Financial Report
1st Apr 202210:17 amRNSHolding(s) in Company
1st Apr 202210:09 amRNSHolding(s) in Company
30th Mar 20222:56 pmRNSDirector/PDMR Shareholding
30th Mar 20222:54 pmRNSDirector/PDMR Shareholding
25th Mar 20227:00 amRNSAnnual Financial Report
17th Feb 20227:00 amRNSDirectorate Change
14th Jan 20227:00 amRNSUpdate on Secondary Placing
13th Jan 20227:00 amRNSProposed Secondary Placing
4th Jan 20227:00 amRNSInvestor Presentation
26th Nov 20217:00 amRNS3rd Quarter Results
22nd Nov 202110:47 amRNSHolding(s) in Company
15th Oct 20219:55 amRNSHolding(s) in Company
15th Oct 20217:00 amRNSKepler Trust Intelligence: New Research
27th Aug 20217:00 amRNSInterim results and Quarterly Dividend
25th Jun 20213:14 pmRNSHolding(s) in Company
27th May 20212:15 pmRNSAGM Statement
27th May 202111:51 amRNSQuarterly NAV and Dividend Announcement
29th Apr 20211:01 pmRNSHolding(s) in Company
19th Apr 20217:00 amRNSAnnual Financial Report
26th Mar 20217:00 amRNSFinal Results
24th Mar 20217:00 amRNSInvestment Update
8th Feb 20213:00 pmRNSHolding(s) in Company
9th Dec 20209:22 amRNSHolding(s) in Company
27th Nov 202010:52 amRNSHolding(s) in Company
25th Nov 20209:18 amRNSKepler Trust Intelligence: New Research
20th Nov 20207:00 amRNSQuarterly results and dividend announcement
15th Oct 20204:09 pmRNSNon-Executive Director Declaration
18th Sep 20202:09 pmRNSDirector/PDMR Shareholding
16th Sep 20202:24 pmRNSDirector/PDMR Shareholding
15th Sep 20203:42 pmRNSHolding(s) in Company
1st Sep 202012:24 pmRNSDirector/PDMR Shareholding
21st Aug 20207:00 amRNSInterim Results
20th Jul 20207:00 amRNSNon-Executive Director Declaration
17th Jul 20207:00 amRNSAppointment of Corporate Broker
9th Jun 20209:57 amRNSHolding(s) in Company
4th Jun 20207:00 amRNSDirectorate Change
22nd May 20204:11 pmRNSHolding(s) in Company
21st May 20207:00 amRNSFirst Quarter Results and Dividend Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.